As TMEM230 sequence is conserved in human and zebrafish, we investigated whether TMEM230 is expressed in human tumors and may represent a promising novel drug target for antiangiogenic or antitumor therapy to restrict GBM tumor cell properties and tumor cell promoted angiogenesis. The gene discussed is TMEM230; the disease is glioblastoma.